ECSP088723A - Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos - Google Patents

Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos

Info

Publication number
ECSP088723A
ECSP088723A EC2008008723A ECSP088723A ECSP088723A EC SP088723 A ECSP088723 A EC SP088723A EC 2008008723 A EC2008008723 A EC 2008008723A EC SP088723 A ECSP088723 A EC SP088723A EC SP088723 A ECSP088723 A EC SP088723A
Authority
EC
Ecuador
Prior art keywords
medicines
preparation
enantiomerically pure
agonists
procedures
Prior art date
Application number
EC2008008723A
Other languages
English (en)
Inventor
Peter Sieger
Uwe Ries
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP088723A publication Critical patent/ECSP088723A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos enantioméricamente puros de la fórmula 1 1en donde los radicales n, B, X, R1, m e Ym- pueden tener los significados mencionados en las reivindicaciones y en la descripción, a procedimientos para su preparación, así como a su preparación como medicamentos, en especial como medicamentos para el tratamiento de enfermedades de las vías respiratorias.
EC2008008723A 2006-03-15 2008-09-08 Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos ECSP088723A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06111191 2006-03-15
EP06111342 2006-03-17
EP06111338 2006-03-17

Publications (1)

Publication Number Publication Date
ECSP088723A true ECSP088723A (es) 2008-10-31

Family

ID=38006901

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008723A ECSP088723A (es) 2006-03-15 2008-09-08 Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos

Country Status (16)

Country Link
US (2) US7534789B2 (es)
EP (1) EP1996581A1 (es)
JP (1) JP2009530245A (es)
KR (1) KR20080106973A (es)
AR (1) AR059836A1 (es)
AU (1) AU2007224420A1 (es)
BR (1) BRPI0709601A2 (es)
CA (1) CA2643026A1 (es)
EA (1) EA200801894A1 (es)
EC (1) ECSP088723A (es)
MX (1) MX2008011700A (es)
NO (1) NO20083508L (es)
PE (1) PE20080142A1 (es)
TW (1) TW200804360A (es)
UY (1) UY30207A1 (es)
WO (1) WO2007104772A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
PE20080142A1 (es) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
SG11201603383VA (en) 2013-10-31 2016-05-30 Allergan Inc Prostamide-containing intraocular implants and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080176744A1 (en) 2005-03-10 2008-07-24 Basf Aktiengesellschaft Use of 4-Aminopyrimidines for Controlling Harmful Fungi, Novel 4-Aminopyrimidines, Processes for Their Preparation and Compositions Comprising Them
CA2642239A1 (en) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
PE20080142A1 (es) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion

Also Published As

Publication number Publication date
CA2643026A1 (en) 2007-09-20
WO2007104772A1 (de) 2007-09-20
WO2007104772A9 (de) 2007-11-22
MX2008011700A (es) 2008-09-24
NO20083508L (no) 2008-09-30
EA200801894A1 (ru) 2009-02-27
EP1996581A1 (de) 2008-12-03
PE20080142A1 (es) 2008-04-14
TW200804360A (en) 2008-01-16
JP2009530245A (ja) 2009-08-27
AR059836A1 (es) 2008-04-30
UY30207A1 (es) 2007-10-31
US7534789B2 (en) 2009-05-19
AU2007224420A1 (en) 2007-09-20
US20070249595A1 (en) 2007-10-25
BRPI0709601A2 (pt) 2011-07-19
US20090306068A1 (en) 2009-12-10
KR20080106973A (ko) 2008-12-09
US7939658B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
ECSP077331A (es) Nuevos betamiméticos para el tratamiento de enfermedades de vías respiratorias
HN2009000784A (es) Dihidropirazolonas sustituidas
CR20120264A (es) Compuestos
CO6491058A2 (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
GT201300243A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
UY28473A1 (es) Nuevos compuestos
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CR20130339A (es) Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos
PE20050255A1 (es) Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos
CU24037B1 (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
UY31310A1 (es) Ácidos 6-fenilnicotínicos sustituidos y su uso
ECSP066734A (es) Derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico, métodos para su producción y su uso como medicamentos
UY29079A1 (es) Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones
ECSP066948A (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
UY28861A1 (es) Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
CU20090216A7 (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
ECSP066770A (es) Nuevos ésteres de quinuclidina cuaternizados
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
ECSP099082A (es) Beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos
UY28896A1 (es) Formulaciones en polvo para la inhalación , las cuales contienen beta-agonistas enantioméricamente puros
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
AR062475A1 (es) Combinaciones farmacologicas para el tratameinto de enfermedades de las vias aereas
CO6382113A2 (es) Compuestos quimicos